Niagen Bioscience, Inc. SEC filings NAGE
Niagen Bioscience, Inc. has 981 filings in SEC EDGAR's recent list, going back to Jan 18, 2007. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 4, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 4, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 6, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 8, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 14, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 12, 2021 | Dec 31, 2020 |
| 10-K/A | Amended annual report | May 18, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 10, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 7, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 15, 2018 | Dec 30, 2017 |
| 10-K | Annual report | Mar 16, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 17, 2016 | Jan 2, 2016 |
| 10-K | Annual report | Mar 19, 2015 | Jan 3, 2015 |
| 10-K | Annual report | Mar 27, 2014 | Dec 28, 2013 |
| 10-K | Annual report | Mar 29, 2013 | Dec 29, 2012 |
| 10-K/A | Amended annual report | Apr 30, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Mar 15, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Mar 16, 2011 | Jan 1, 2011 |
| 10-K/A | Amended annual report | Apr 30, 2010 | Jan 2, 2010 |
| 10-K | Annual report | Mar 31, 2010 | Jan 2, 2010 |
| ARS | Annual report to shareholders | Apr 16, 2009 | Dec 31, 2008 |
| 10-K | Annual report | Apr 3, 2009 | Jan 3, 2009 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- NAGE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1386570
- Former names
- ChromaDex Corp. (until Mar 10, 2025); CODY RESOURCES, INC. (until Jun 24, 2008)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.